申请人:——
公开号:US20040259912A1
公开(公告)日:2004-12-23
Novel benzene derivatives represented by the formula (I):
1
wherein R
1
, R
4
and R
6
each independently represents a hydrogen atom, a halogen atom or a hydrocarbon group, R
2
represents a hydrocarbon group or a heterocyclic group, R
3
represents a hydrocarbon group, NR
7′
R
7
or OR
8
(wherein R
7′
represents a hydrogen atom or a hydrocarbon group, R
7
represents a non-aromatic group, or R
7′
and R
7
may form a ring with the adjacent nitrogen atom, and R
8
represents a hydrocarbon group or a heterocyclic group), R
5
represents a hydrocarbon group or a heterocyclic group (except for a quinolyl group), R
5′
represents a hydrogen atom, or a hydrocarbon group, or R
5
and R
5′
may form a ring with the adjacent nitrogen atom, and R
5″
represents a hydrogen atom or a hydrocarbon group, which have vanilloid receptor agonist activity and are useful as a drug such as an analgesic and an agent for preventing and/or treating urinary frequency and/or urinary incontinence.
式(I)所表示的新型苯衍生物,其中R1、R4和R6各自独立地表示氢原子、卤素原子或烃基,R2表示烃基或杂环基,R3表示烃基、NR7′R7或OR8(其中R7′表示氢原子或烃基,R7表示非芳香族基团,或R7′和R7可与相邻的氮原子形成环,R8表示烃基或杂环基),R5表示烃基或杂环基(除了喹啉基团),R5′表示氢原子或烃基,或R5和R5′可与相邻的氮原子形成环,R5″表示氢原子或烃基,具有vanilloid受体激动剂活性,并且可用作药物,例如镇痛剂和预防和/或治疗尿频和/或尿失禁的药剂。